Microbot Medical Inc. (NASDAQ:MBOT - Get Free Report)'s stock price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.26 and traded as high as $1.54. Microbot Medical shares last traded at $1.44, with a volume of 469,348 shares trading hands.
Analyst Upgrades and Downgrades
Separately, HC Wainwright raised their target price on shares of Microbot Medical from $7.00 to $9.00 and gave the stock a "buy" rating in a research note on Friday, January 24th.
Check Out Our Latest Report on MBOT
Microbot Medical Price Performance
The company has a market cap of $50.03 million, a price-to-earnings ratio of -1.80 and a beta of 1.60. The firm has a 50-day moving average price of $1.83 and a 200 day moving average price of $1.26.
Institutional Inflows and Outflows
An institutional investor recently raised its position in Microbot Medical stock. Geode Capital Management LLC increased its holdings in shares of Microbot Medical Inc. (NASDAQ:MBOT - Free Report) by 7.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 142,659 shares of the biotechnology company's stock after acquiring an additional 10,442 shares during the quarter. Geode Capital Management LLC owned about 0.70% of Microbot Medical worth $160,000 as of its most recent filing with the SEC. 16.30% of the stock is owned by institutional investors and hedge funds.
About Microbot Medical
(
Get Free Report)
Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Microbot Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Microbot Medical wasn't on the list.
While Microbot Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
